Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein

International Journal of Cancer

Volumn 77, Issue 5, 1998, Pages 674-678

  Castrén, Katariina ^a   Vähäkangas, Kirsi ^a   Heikkinen, Eini ^b   Ranki, Annamari ^b,c  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS DNA;

ARTICLE; BOWENOID PAPULOSIS; CARCINOMA IN SITU; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; ERYTHROPLASIA; GENE MUTATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MALE GENITAL SYSTEM DISEASE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; WART VIRUS;

BIOPSY; BOWEN'S DISEASE; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CONDYLOMATA ACUMINATA; EXONS; FEMALE; GENES, P53; GENITAL DISEASES, MALE; GENITAL NEOPLASMS, MALE; HUMANS; MALE; MUTATION; PAPILLOMAVIRIDAE; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 2642708371     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980831)77:5<674::AID-IJC2>3.0.CO;2-S     Document Type: Article

References (23)

1. BEER-ROMERO, P., GLASS, S. and ROLFE, M., Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells. Oncogene, 14, 595-602 (1997).
2. BUSBY-EARLE, R.M.C., STEEL, C.M., WILLIAMS, A.R.W., COHEN, B. and BIRD, C.C., Papillomaviruses, p53, and cervical cancer. Lancet, 339, 1350 (1992).
3. CROOK, T., FISHER, C, MASTERSON, P.J. and VOUSDEN, K.H., Modulation of transcriptional properties of p53 by HPV E6. Oncogene, 9, 1225-1230 (1994).
4. CROOK, T., WREDE. D., TIDY, J.A., MASON, P.W., EVANS, E.J. and VOUSDEN, K.H., Clonal p53 mutation in primary cervical cancer: association with human papillomavirus-negative tumors. Lancet, 339, 1070-1073 (1992).
5. GOTTLIEB, T.M. and OREN, M., p53 in growth control and neoplasia. Biochim. biophys. Acta, 1287, 77-102 (1996).
6. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
7. HALL, P.A., MCKEE, P.H., Du P, MENAGE, H., DOVER, R. and LANE, D.P., High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8, 203-207, (1993).
8. KAEBLING, M., BURK, R., ATKIN, N., JOHNSON, A. and KLINGER, H., Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas. Lancet, 340, 140-142 (1992).
9. KIM, Y.T., THOMAS, N.F., KESSIS, T.D., WILKINSON, E.J., HEDRICK, L. and CHO, K.R., p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas. Hum. Pathol., 27, 389-395 (1996).
10. LAM, K.Y., CHAN, A.C.L., CHAN, K.W., LEUNG, M.L. and SRIVASTAVA, G., Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Europ. J. Surg. Oncol., 21, 613-616 (1995).
11. 2)-laser therapy cures macroscopic lesions, but viral genome is not eradicated in men with therapy-resistant HPV infection. Sex. Transm. Dis., 21, 297-303 (1994).
12. MILDE-LANGOSCH, K., ALBRECHT, K., JORAM, S., SCHLECHTE, H., GIESSING, M. and LÖNING, T., Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int. J. Cancer, 63, 639-645 (1995).
13. NUORVA, K., SOINI, Y., KAMEL, D., PÖLLÄNEN, R., BLOIGU, R., VÄHÄKANGAS, K. and PÄÄKKÖ, P., p53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis. Int. J. Cancer, 64, 424-429 (1995).
14. PÖLLÄNEN, R., SOINI, Y, VÄHÄKANGAS, K., PÄÄKKÖ, P. and LEHTO, V.-P., Aberrant p53 protein expression in cervical intra-epithelial neoplasia. Histopathology, 23, 471-474 (1993).
15. RANKI, A., LASSUS, J. and NIEMI, K.M. Relation of p53 tumor suppressor protein expression to human papillomavirus (HPV) DNA and to cellular atypia in male genital warts and premalignant lesions. Acta Dermatol. Venereol., 75, 180-186 (1995).
16. SCHEFFNER, M., WERNESS, B.A., HUIBREGTSE, J.M., LEVINE, A.J. and HOWLEY, P.M., The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136 (1990).
17. SOINI, Y., KAMEL, D., PÄÄKKÖ, P., LEHTO, V.-P., OIKARINEN, A. and VÄHÄKANGAS, K., Aberrant accumulation of p53 associates with Ki67 and mitotic count in benign skin lesions. Brit. J. Dermatol., 131, 514-520 (1994).
18. SUZUKI, H., SATO, N., KODOMA, T., OKANO, T., ISAKA, S., SHIRASAWA, H., SIMIZU, B. and SHIMAZAKI, J., Detection of human papillomavirus DNA and state of p53 gene in Japanese penile cancer. Jpn. J. Clin. Oncol., 24, 1-6 (1994).
19. TAPIAINEN, T., JÄRVINEN, K., PÄÄKKÖ, P., BJELOGRLIC, N. and VÄHÄKANGAS, K., TPA decreases the p53 response to benzo(a)pyrene-DNA-adducts in vivo in mouse skin. Carcinogenesis, 17, 1377-1380 (1996).
20. VÄHÄKANGAS, K.H., SAMET, J.M., METCALF, R.A., WELSH, J.A., BENNETT, W.P., LANE, D.P. and HARRIS, C.C., Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet, 339, 576-580 (1992).
21. WELSH, J.A., CASTRÉN, K. and VÄHÄKANGAS, K.H., Single-strand conformation polymorphism analysis to detect p53 mutations: characterization and development of controls. Clin. Chem., 43, 2251-2255 (1997).
22. WERNESS, B.A., LEVINE, A.J. and HOWLEY, P.M., Association of human papillomavirus types 16 and 18 proteins with p53. Science, 248, 76-79 (1990).
23. ZUR HAUSEN, H., Viruses and human cancer. Science, 254, 1167-1173 (1991).